Bionomics Current Ratio 2022-2024 | NEUP
Bionomics current ratio from 2022 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Bionomics Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-09-30 |
$0.01B |
$0.00B |
3.30 |
| 2024-06-30 |
$0.01B |
$0.00B |
3.45 |
| 2023-12-31 |
$0.01B |
$0.00B |
3.81 |
| 2023-09-30 |
$0.00B |
|
0.00 |
| 2023-06-30 |
$0.01B |
$0.00B |
4.87 |
| 2022-12-31 |
$0.02B |
$0.00B |
9.05 |
| 2022-06-30 |
$0.03B |
$0.00B |
12.46 |
| 2021-06-30 |
$0.02B |
$0.00B |
13.10 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
